MORFINO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 222
AS - Asia 72
NA - Nord America 51
AF - Africa 1
OC - Oceania 1
SA - Sud America 1
Totale 348
Nazione #
IT - Italia 143
US - Stati Uniti d'America 49
SG - Singapore 42
IE - Irlanda 29
DE - Germania 14
FI - Finlandia 12
AT - Austria 9
CN - Cina 9
PK - Pakistan 9
GB - Regno Unito 7
IN - India 6
FR - Francia 5
BD - Bangladesh 3
HK - Hong Kong 3
CA - Canada 2
NL - Olanda 2
AU - Australia 1
BE - Belgio 1
CO - Colombia 1
ET - Etiopia 1
Totale 348
Città #
Singapore 34
Dublin 29
Pisa 26
Milan 20
Boardman 16
Palermo 10
Livorno 9
Rome 9
Munich 8
Santa Clara 7
Helsinki 6
Lappeenranta 6
Zirl 6
Bengaluru 4
Genoa 4
Lahore 4
Shenzhen 4
Zhengzhou 4
Altavilla Vicentina 3
Florence 3
Gozzano 3
Hong Kong 3
Lyon 3
Partinico 3
Vienna 3
Washington 3
Amsterdam 2
Assago 2
Bologna 2
Canzo 2
Cascina 2
Hounslow 2
New York 2
Nuremberg 2
Springfield 2
Toronto 2
Trapani 2
Trento 2
Verona 2
Albavilla 1
Ashburn 1
Bagheria 1
Brussels 1
Corciano 1
Custonaci 1
Delhi 1
Forlì 1
Gujranwala 1
Hanover 1
Kilburn 1
Medellín 1
Naples 1
New Bedfont 1
Padova 1
Perugia 1
Pune 1
Reggio Emilia 1
San Michele di Serino 1
Sassari 1
Southwark 1
Treviso 1
Turin 1
Totale 279
Nome #
Unmet needs in end-of-life care for heart failure patients 78
Amyloid seeding as a disease mechanism and treatment target in transthyretin cardiac amyloidosis 63
Screening the health status of people working in a university 31
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 25
The Fondazione Toscana Gabriele Monasterio app: a digital health system to improve wellbeing of inpatients with heart or lung disease 24
Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis 23
Valvular heart disease in patients with cardiac amyloidosis 18
Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy 17
Cardiovascular toxicity from therapies for light chain amyloidosis 16
[Treatment of cardiac fibrosis: from neurohormonal antagonists to CAR-T cells] 14
The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis 14
Approccio critico all’interpretazione dei trial cardiovascolari con risultati neutri o negativi 12
Biomarkers of HFpEF: Natriuretic Peptides, High-Sensitivity Troponins and Beyond 8
Plasma acylcarnitine, risk for heart failure or atrial fibrillation, and effects of the Mediterranean diet or obesity 7
Disease features and management of cardiomyopathies in women 6
Pathophysiology of Cardiac Amyloidosis 5
Colchicine added to standard therapy further reduces fibrosis in pigs with myocardial infarction 5
Totale 366
Categoria #
all - tutte 3.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.408


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202348 0 0 0 0 12 4 1 6 17 2 4 2
2023/2024155 1 1 26 5 12 4 16 7 24 12 13 34
2024/2025163 44 37 74 8 0 0 0 0 0 0 0 0
Totale 366